A detailed history of Vanguard Group Inc transactions in Kempharm, Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,833,415 shares of KMPH stock, worth $9.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,833,415
Previous 1,704,006 7.59%
Holding current value
$9.06 Million
Previous $8.42 Million 7.6%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
N/A
129,409 Added 7.59%
1,833,415 $9.06 Million
Q1 2024

May 10, 2024

BUY
N/A
58,866 Added 3.58%
1,704,006 $8.42 Million
Q4 2023

Feb 14, 2024

BUY
N/A
32,639 Added 2.02%
1,645,140 $8.13 Million
Q3 2023

Nov 14, 2023

BUY
N/A
3,154 Added 0.2%
1,612,501 $7.97 Million
Q2 2023

Aug 14, 2023

BUY
$4.94 - $6.29 $674,576 - $858,924
136,554 Added 9.27%
1,609,347 $7.95 Million
Q1 2023

May 15, 2023

BUY
$4.13 - $6.27 $291,578 - $442,661
70,600 Added 5.03%
1,472,793 $8.1 Million
Q4 2022

Feb 10, 2023

BUY
$4.12 - $5.62 $88,806 - $121,139
21,555 Added 1.56%
1,402,193 $6.44 Million
Q2 2022

Aug 12, 2022

SELL
$4.02 - $5.21 $547,821 - $709,987
-136,274 Reduced 8.98%
1,380,638 $6.16 Million
Q1 2022

May 13, 2022

BUY
$5.0 - $9.26 $166,835 - $308,978
33,367 Added 2.25%
1,516,912 $7.63 Million
Q4 2021

Feb 14, 2022

SELL
$7.6 - $10.26 $830,854 - $1.12 Million
-109,323 Reduced 6.86%
1,483,545 $12.9 Million
Q3 2021

Nov 12, 2021

BUY
$8.72 - $13.31 $3.35 Million - $5.11 Million
383,821 Added 31.75%
1,592,868 $14.9 Million
Q2 2021

Aug 13, 2021

BUY
$8.52 - $15.47 $10.3 Million - $18.7 Million
1,209,047 New
1,209,047 $15.5 Million

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.